Literature DB >> 25485347

Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.

Liya Wang, Xiaodong Zhong, Weiping Qian, Jing Huang, Zehong Cao, Qiqi Yu, Malgorzata Lipowska, Run Lin, Andrew Wang, Lily Yang, Hui Mao.   

Abstract

PURPOSE: The purpose of this study was to investigate an ultrashort echo time (UTE) imaging approach for improving the detection of receptor targeted magnetic nanoparticles in cancer xenograft models using positive contrast.
MATERIALS AND METHODS: Iron oxide nanoparticle (IONP) conjugated with tumor targeting ligands were prepared. A 3D UTE gradient echo sequence with the shortest TE of 0.07 msec was evaluated on a 3T magnetic resonance imaging (MRI) scanner using IONP solution, cancer cells bound with targeted IONPs and orthotopic human pancreatic, and breast cancer mouse models administered tumor targeting IONPs. A simulation was performed to analyze contrast-to-noise ratios (CNR) of UTE images and subtraction of the images obtained UTE and longer TE (SubUTE). T2-weighted imaging and T2 relaxometry mapping were applied for comparison and validation.
RESULTS: UTE and SubUTE images showed positive contrast in pancreatic tumors accumulated with EGFR targeted ScFvEGFR-IONPs and mammary tumors accumulated with uPAR targeted ATF-IONPs. The positive contrast observed in UTE images was consistent with the negative contrast observed in the T2-weighted images. A flip angle of 10° and a maximal possible TE for the second echo are suitable for SubUTE imaging.
CONCLUSION: UTE imaging is capable of detecting tumor targeted IONPs in vivo with positive contrast in molecular MRI applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25485347      PMCID: PMC4260814          DOI: 10.1002/jmri.24453

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  40 in total

1.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.

Authors:  L Josephson; C H Tung; A Moore; R Weissleder
Journal:  Bioconjug Chem       Date:  1999 Mar-Apr       Impact factor: 4.774

2.  Adiabatic RARE imaging.

Authors:  Robin A de Graaf; Douglas L Rothman; Kevin L Behar
Journal:  NMR Biomed       Date:  2003-02       Impact factor: 4.044

3.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

4.  Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles.

Authors:  Charles H Cunningham; Takayasu Arai; Phillip C Yang; Michael V McConnell; John M Pauly; Steven M Conolly
Journal:  Magn Reson Med       Date:  2005-05       Impact factor: 4.668

5.  Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON).

Authors:  Matthias Stuber; Wesley D Gilson; Michael Schär; Dorota A Kedziorek; Lawrence V Hofmann; Saurabh Shah; Evert-Jan Vonken; Jeff W M Bulte; Dara L Kraitchman
Journal:  Magn Reson Med       Date:  2007-11       Impact factor: 4.668

Review 6.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

Review 7.  Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.

Authors:  Jason S Weinstein; Csanad G Varallyay; Edit Dosa; Seymur Gahramanov; Bronwyn Hamilton; William D Rooney; Leslie L Muldoon; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-16       Impact factor: 6.200

8.  Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.

Authors:  C Chambon; O Clement; A Le Blanche; E Schouman-Claeys; G Frija
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

9.  Dual inversion recovery, ultrashort echo time (DIR UTE) imaging: creating high contrast for short-T(2) species.

Authors:  Jiang Du; Atsushi M Takahashi; Won C Bae; Christine B Chung; Graeme M Bydder
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

10.  Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging.

Authors:  Bishnu P Joshi; Thomas D Wang
Journal:  Cancers (Basel)       Date:  2010-06-11       Impact factor: 6.639

View more
  12 in total

1.  Tracking and Quantification of Magnetically Labeled Stem Cells using Magnetic Resonance Imaging.

Authors:  Forrest Goodfellow; Gregory A Simchick; Luke J Mortensen; Steven L Stice; Qun Zhao
Journal:  Adv Funct Mater       Date:  2016-02-17       Impact factor: 18.808

Review 2.  Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.

Authors:  Lei Zhu; Zhiyang Zhou; Hui Mao; Lily Yang
Journal:  Nanomedicine (Lond)       Date:  2016-11-23       Impact factor: 5.307

3.  Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches.

Authors:  Jing Huang; Yuancheng Li; Anamaria Orza; Qiong Lu; Peng Guo; Liya Wang; Lily Yang; Hui Mao
Journal:  Adv Funct Mater       Date:  2016-02-05       Impact factor: 18.808

Review 4.  Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.

Authors:  Jasmine M Miller-Kleinhenz; Erica N Bozeman; Lily Yang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-05-12

5.  Establishing the overlap of IONP quantification with echo and echoless MR relaxation mapping.

Authors:  Hattie L Ring; Jinjin Zhang; Nathan D Klein; Lynn E Eberly; Christy L Haynes; Michael Garwood
Journal:  Magn Reson Med       Date:  2017-06-26       Impact factor: 4.668

6.  Quantification and biodistribution of iron oxide nanoparticles in the primary clearance organs of mice using T1 contrast for heating.

Authors:  Jinjin Zhang; Hattie L Ring; Katie R Hurley; Qi Shao; Cathy S Carlson; Djaudat Idiyatullin; Navid Manuchehrabadi; P Jack Hoopes; Christy L Haynes; John C Bischof; Michael Garwood
Journal:  Magn Reson Med       Date:  2016-09-25       Impact factor: 4.668

7.  Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment.

Authors:  Meijia Wu; Shengwu Huang
Journal:  Mol Clin Oncol       Date:  2017-08-28

8.  Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.

Authors:  Susanna W L de Geus; Leonora S F Boogerd; Rutger-Jan Swijnenburg; J Sven D Mieog; Willemieke S F J Tummers; Hendrica A J M Prevoo; Cornelis F M Sier; Hans Morreau; Bert A Bonsing; Cornelis J H van de Velde; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

9.  Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.

Authors:  Minati Satpathy; Liya Wang; Rafal J Zielinski; Weiping Qian; Y Andrew Wang; Aaron M Mohs; Brad A Kairdolf; Xin Ji; Jacek Capala; Malgorzata Lipowska; Shuming Nie; Hui Mao; Lily Yang
Journal:  Theranostics       Date:  2019-01-24       Impact factor: 11.556

Review 10.  Going even smaller: Engineering sub-5 nm nanoparticles for improved delivery, biocompatibility, and functionality.

Authors:  Manman Xie; Yaolin Xu; Jing Huang; Yuancheng Li; Liya Wang; Lily Yang; Hui Mao
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.